3 results
Approved WMORecruiting
Safety and efficacy objectives:The objective is to compare the safety and efficacy of masitinib at 6 of 7.5 mg/kg/day to imatinib at 400 or 600 mg, in patients with gastro-intestinal stromal tumour in first line medical treatment.
Approved WMORecruiting
The objective is to compare the efficacy and safety of masitinib 12 mg/kg/day to sinutinib 50 mg/day
Approved WMORecruiting
1. Are telemedicine and FTF-evaluation similar?2. Are TM-evaluation from a general practitioners office and FTF-evaluation similar? 3. How do parents/patients value the TM evaluation?4. How do general practitioners and paediatricians value the TM…